height-GaP

1. height-GaP is associated with coronary heart disease in humans (aHR 1.64, 95% CI 1.49-1.81).

   “coronary heart disease (aHR: 1.64 95%CI: 1.49-1.81).”

   Humanshighest-to-lowest height-GaP deficit quartilen = 483,385

   Quantifying the impact of early life growth adversity on later life health

   Communications medicine·17 Nov 2025

More on Coronary heart disease

1. height-GaP is associated with atherosclerotic cardiovascular disease in humans (aHR 1.32, 95% CI 1.23-1.42).

   “atherosclerotic cardiovascular disease (aHR: 1.32 95%CI: 1.23-1.42)”

   Humanshighest-to-lowest height-GaP deficit quartilen = 483,385

   Quantifying the impact of early life growth adversity on later life health

   Communications medicine·17 Nov 2025

More on Atherosclerotic cardiovascular disease

1. height-GaP is associated with mortality in humans (aHR 1.25, 95% CI 1.21-1.29).

   “height-GaP deficit is associated with death from all-causes (adjusted hazard ratio comparing highest-to-lowest height-GaP deficit quartile [aHR]: 1.25 95%CI: 1.21-1.29)”

   Humanshighest-to-lowest height-GaP deficit quartilen = 483,385

   Quantifying the impact of early life growth adversity on later life health

   Communications medicine·17 Nov 2025

1. Breastfeeding is associated with height-GaP in humans (p < 0.01).

   “less breastfeeding are associated with larger adult height-GaP deficit (p < 0.01).”

   Humansn = 4,582

   Quantifying the impact of early life growth adversity on later life health

   Communications medicine·17 Nov 2025

More on Breastfeeding

1. Tobacco smoke exposure is associated with height-GaP in humans (p < 0.01).

   “tobacco smoke exposure and less breastfeeding are associated with larger adult height-GaP deficit (p < 0.01).”

   Humansn = 4,582

   Quantifying the impact of early life growth adversity on later life health

   Communications medicine·17 Nov 2025

More on Tobacco smoke exposure